J.M. Krahn

This study shows heparan sulfate inhibits cathepsin K collagenase activity while preserving peptidase activity, revealing HS as a potential therapeutic target for bone resorption diseases.

The paper builds predictive models for drug sensitivity using gene expression data from cancer cell lines and applies them to predict drug responses in tumor and normal tissues.